Meadow Creek Investment Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$811K Hold
6,188
0.02% 544
2019
Q2
$751K Hold
6,188
0.01% 571
2019
Q1
$763K Hold
6,188
0.02% 548
2018
Q4
$725K Hold
6,188
0.02% 502
2018
Q3
$773K Buy
6,188
+1,598
+35% +$176K 0.02% 552
2018
Q2
$392K Hold
4,590
0.01% 751
2018
Q1
$277K Hold
4,590
0.01% 878
2017
Q4
$242K Buy
4,590
+374
+9% +$19.7K 0.01% 927
2017
Q3
$236K Buy
4,216
+544
+15% +$28.8K 0.01% 864
2017
Q2
$231K Buy
3,672
+1,666
+83% +$97K 0.01% 827
2017
Q1
$103K Sell
2,006
-238
-11% -$11.4K ﹤0.01% 941
2016
Q4
$96K Buy
+2,244
New +$95.4K ﹤0.01% 938

Other funds holding AMED

Meadow Creek Investment Management's AMED Position: Q3 2019 in Review

Meadow Creek Investment Management held its Amedisys (AMED) position steady in Q3 2019 at 6,188 shares worth $811K. The position accounts for 0.02% of the portfolio, ranked #544.

Meadow Creek Investment Management first reported a position in AMED in Q4 2016 and has held it in 12 quarters since. 283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

  • Meadow Creek Investment Management held 6,188 shares of Amedisys worth $811K as of Q3 2019.
  • Meadow Creek Investment Management left its Amedisys share count unchanged in Q3 2019.
  • Amedisys made up 0.02% of Meadow Creek Investment Management's portfolio in Q3 2019, its #544 holding.
  • Meadow Creek Investment Management first reported a position in Amedisys in Q4 2016 and has held it in 12 quarters since.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.